MEX:2269 (China)  
WuXi Biologics (Cayman) Inc logo

WuXi Biologics (Cayman) Inc

MXN 133.63 (0%) Sep 30
P/E:
42.74
P/B:
5.00
Market Cap:
MXN 518.63B ($ 25.83B)
Enterprise V:
MXN 503.19B ($ 25.06B)
Volume:
-
Avg Vol (2M):
189.37K
Also Trade In:
Volume:
-
Market Cap MXN:
518.63B
Market Cap $:
25.83B
PE Ratio:
42.74
Avg Vol (2-Month):
189.37K
Enterprise Value MXN:
503.19B
Enterprise Value $:
25.06B
PB Ratio:
5.00
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
WuXi Biologics ("WuXi") is a contract development and manufacturing organization, or "CDMO," for biologic drugs. It was founded in 2010 as part of WuXi AppTec and listed on the Hong Kong Stock Exchange in 2017. WuXi provides comprehensive services from conception to commercialization, including drug discovery, clinical and commercial manufacturing, and various support services such as process validation, viral clearance studies, product and cell line characterization, stability studies, and others. It does not conduct clinical trials.
Name Current Vs Industry Vs History
Cash-To-Debt 2.24
Equity-to-Asset 0.73
Debt-to-Equity 0.13
Debt-to-EBITDA 0.88
Interest Coverage 103.44
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.59
Distress
Grey
Safe
Beneish M-Score -1.67
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 0.03
9-Day RSI 1.3
14-Day RSI 5.79
6-1 Month Momentum % 22.12
12-1 Month Momentum % -42.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.3
Quick Ratio 2.06
Cash Ratio 1.1
Days Inventory 94.5
Days Sales Outstanding 105.85
Days Payable 36.56

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5

Financials (Next Earnings Date:2023-03-22 Est.)

MEX:2269's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil MXN) 40,867.314
EPS (TTM) (MXN) 2.883
Beta 0
Volatility % 66.07
14-Day RSI 5.79
14-Day ATR (MXN) 1.9363
20-Day SMA (MXN) 157.315
12-1 Month Momentum % -42.39
52-Week Range (MXN) 133.63 - 314.16
Shares Outstanding (Mil) 4,265.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

WuXi Biologics (Cayman) Inc Filings

Document Form Filing Date
No Filing Data

WuXi Biologics (Cayman) Inc Analysis

Share your research